About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: September 22, 2009
FDLI Conference Part 3 – Wrap Up of Day 1
I had planned on live-blogging from the conference, but there was a paucity of electric outlets at the venue and my battery was exceptionally lazy. Following her speech, during question and answer, I asked Dr. Woodcock the question that was … Continue reading
Posted in FDA Policy
2 Comments